CHEK2*1100delC is not an important high-risk gene in families with hereditary prostate cancer in southern Sweden - Concepedia

Concepedia

Publication | Closed Access

CHEK2*1100delC is not an important high-risk gene in families with hereditary prostate cancer in southern Sweden

17

Citations

13

References

2006

Year

Magnus Wagenius, Åke Borg, Lovisa Johansson, Aleksander Giwercman, Ola Bratt

Scandinavian Journal of Urology and Nephrology

Abstract

The CHEK2 1100delC mutation is not a clinically important high-risk gene for hereditary prostate cancer susceptibility in the population of southern Sweden.

References

	Year	Citations
Environmental and Heritable Factors in the Causation of Cancer — Analyses of Cohorts of Twins from Sweden, Denmark, and Finland Paul Lichtenstein, Niels V. Holm, Pia K. Verkasalo, New England Journal of Medicine	2000	4.1K
Low-penetrance susceptibility to breast cancer due to CHEK2*1100delC in noncarriers of BRCA1 or BRCA2 mutations Deborah J. Thompson, Richard S. Houlston, Catherine Phelan Nature Genetics Breast OncologyMedicineBrca2 MutationsPathologyCancer Genomics	2002	1.1K
Chk2/hCds1 functions as a DNA damage checkpoint in G<sub>1</sub>by stabilizing p53 Nabil Chehab, Asra Malikzay, Michael Appel, Genes & Development ApoptosisMolecular BiologyCell DeathCell CycleDominant-negative P53 Mutant	2000	784
hCds1-mediated phosphorylation of BRCA1 regulates the DNA damage response Jong‐Soo Lee, Kimberly M. Collins, Alexandra L. Brown, Nature ChromatinGenome InstabilityDna DamageMolecular BiologyCell Death	2000	528
CHEK2*1100delC and Susceptibility to Breast Cancer: A Collaborative Analysis Involving 10,860 Breast Cancer Cases and 9,065 Controls from 10 Studies The American Journal of Human Genetics Breast OncologyOncologyCancer EpidemiologyCancer RiskMedicine	2004	471
Mammalian Chk2 is a downstream effector of the ATM-dependent DNA damage checkpoint pathway Priya Chaturvedi, Wai K Eng, Yuan Zhu, Oncogene ChromatinGenome InstabilityCell RegulationCell DeathDownstream Effector	1999	423
Mutations in CHEK2 Associated with Prostate Cancer Risk Xiangyang Dong, Liang Wang, Ken Taniguchi, The American Journal of Human Genetics UrologyMedicineProstate Cancer RiskCancer GenomicsProstatic Disease	2003	302
A Novel Founder CHEK2 Mutation is Associated with Increased Prostate Cancer Risk Cezary Cybulski, Tomasz Huzarski, Bohdan Górski, Cancer Research Chek2 GeneUrologyCancer RiskCancer EpidemiologyPolish Patients	2004	155
CHEK2 variants associate with hereditary prostate cancer Eija H. Seppälä, Tarja Ikonen, Nina Mononen, British Journal of Cancer Chek2 GeneUrologyMedicineGeneticsGenetic Epidemiology	2003	144
Variants in CHEK2 Other than 1100delC Do Not Make a Major Contribution to Breast Cancer Susceptibility Mieke Schutte, Sheila Seal, Rita Barfoot, The American Journal of Human Genetics Breast OncologyOncologyEngineeringBreast Cancer SusceptibilityMedicine	2003	134

Page 1